Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Decreased nuclear distribution nudE-like 1 enzyme activity in an animal model with dysfunctional disrupted-in-schizophrenia 1 signaling featuring aberrant neurodevelopment and amphetamine-supersensitivity

Full text
Author(s):
Nani, V, Joao ; Fonseca, Matheus C. [1] ; Engi, Sheila A. [2] ; Perillo, Mayara G. [2] ; Dias, Carlos S. B. [3] ; Gazarini, Marcos L. [4] ; Korth, Carsten [5] ; Cruz, Fabio C. [2] ; Hayashi, Mirian A. F. [2, 5]
Total Authors: 9
Affiliation:
[1] CNPEM, Lab Nacl Biociencias LNBio, Campinas - Brazil
[2] Nani, Joao, V, Univ Fed Sao Paulo UNIFESP, Dept Farmacol, Sao Paulo - Brazil
[3] CNPEM, LNLS, Campinas - Brazil
[4] Univ Fed Sao Paulo UNIFESP, Dept Biociencias, Santos, SP - Brazil
[5] Heinrich Heine Univ Dusseldorf, Dept Neuropathol, Dusseldorf - Germany
Total Affiliations: 5
Document type: Journal article
Source: JOURNAL OF PSYCHOPHARMACOLOGY; v. 34, n. 4 JAN 2020.
Web of Science Citations: 0
Abstract

Background: Interaction of nuclear-distribution element-like 1 with disrupted-in-schizophrenia 1 protein is crucial for neurite outgrowth/neuronal migration, and this interaction competitively inhibits nuclear-distribution element-like 1 peptidase activity. Nuclear-distribution element-like 1 activity is reduced in antipsychotic-naive first-episode psychosis and in medicated chronic schizophrenia, with even lower activity in treatment-resistant schizophrenia. Aims: The purpose of this study was to investigate in a rat model overexpressing human non-mutant disrupted-in-schizophrenia 1, with consequent dysfunctional disrupted-in-schizophrenia 1 signaling, the relation of nuclear-distribution element-like 1 activity with neurodevelopment and dopamine-related phenotypes. Methods: We measured cell distribution in striatum and cortex by histology and microtomography, and quantified the basal and amphetamine-stimulated locomotion and nuclear-distribution element-like 1 activity (in blood and brain) of transgenic disrupted-in-schizophrenia 1 rat vs wild-type littermate controls. Results: 3D assessment of neuronal cell body number and spatial organization of mercury-impregnated neurons showed defective neuronal positioning, characteristic of impaired cell migration, in striatum/nucleus accumbens, and prefrontal cortex of transgenic disrupted-in-schizophrenia 1 compared to wild-type brains. Basal nuclear-distribution element-like 1 activity was lower in the blood and also in several brain regions of transgenic disrupted-in-schizophrenia 1 compared to wild-type. Locomotion and nuclear-distribution element-like 1 activity were both significantly increased by amphetamine in transgenic disrupted-in-schizophrenia 1, but not in wild-type. Conclusions: Our findings in the transgenic disrupted-in-schizophrenia 1 rat allow us to state that decreased nuclear-distribution element-like 1 activity reflects both a trait (neurodevelopmental phenotype) and a state (amphetamine-induced dopamine release). We thus define here a role for decreased nuclear-distribution element-like 1 peptidase activity both for the developing brain (the neurodevelopmental phenotype) and for the adult (interaction with dopaminergic responses), and present nuclear-distribution element-like 1 activity in a novel way, as unifying neurodevelopmental with dysfunctional dopamine response phenotypes. (AU)

FAPESP's process: 14/50891-1 - INCT 2014: Translational Medicine
Grantee:Jaime Eduardo Cecilio Hallak
Support type: Research Projects - Thematic Grants
FAPESP's process: 18/20014-0 - THE GUT-BRAIN CONNECTION: ROLE OF THE GUT MICROBIOMA IN THE OUTCOME AND DEVELOPMENT OF THE SPORADIC PARKINSON'S DISEASE
Grantee:Matheus de Castro Fonseca
Support type: Regular Research Grants
FAPESP's process: 17/02413-1 - Validation of crotamine as a biomarker and evaluation of its potential use in the therapy of human diseases
Grantee:Mirian Akemi Furuie Hayashi
Support type: Regular Research Grants
FAPESP's process: 19/09207-3 - Study of molecular and cellular mechanisms in mental disorders
Grantee:João Victor Silva Nani
Support type: Scholarships in Brazil - Doctorate